Page last updated: 2024-09-04

birb 796 and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione

birb 796 has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 1 studies

Compound Research Comparison

Studies (birb 796)	Trials (birb 796)	Recent Studies (post-2010) (birb 796)	Studies (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione)	Trials (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione)	Recent Studies (post-2010) (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione)
137	5	80	126	1	84

Protein Interaction Comparison

Protein	Taxonomy	4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (IC50)
[tau protein] kinase	Oryctolagus cuniculus (rabbit)	2
G2/mitotic-specific cyclin-B2	Homo sapiens (human)	10
Cyclin-dependent kinase 1	Homo sapiens (human)	10
Replicase polyprotein 1ab	Severe acute respiratory syndrome-related coronavirus	2.15
Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2	1.145
G2/mitotic-specific cyclin-B1	Homo sapiens (human)	10
Glycogen synthase kinase-3 alpha	Homo sapiens (human)	4.5
Glycogen synthase kinase-3 beta	Homo sapiens (human)	2.0608
G2/mitotic-specific cyclin-B3	Homo sapiens (human)	10

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alder, J; Benitez, R; Davidson, C; Davies, MP; Hayes, JM; Jakupovic, S; Martinez, A; Perez, C; Rzepecka, K; Welsby, P	1

Other Studies

1 other study(ies) available for birb 796 and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione

Article	Year
Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β. Journal of medicinal chemistry, 2021, 02-11, Volume: 64, Issue:3 Topics: Cell Line, Tumor; Drug Design; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; Humans; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Neuroprotective Agents; Phosphorylation; Structure-Activity Relationship; Substrate Specificity; tau Proteins	2021

Article

Year

Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β.

Journal of medicinal chemistry, 2021, 02-11, Volume: 64, Issue:3

Topics: Cell Line, Tumor; Drug Design; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; Humans; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Neuroprotective Agents; Phosphorylation; Structure-Activity Relationship; Substrate Specificity; tau Proteins

2021